Intervention: allogeneic bone marrow transplantation
Found 0 matching trials
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
PHASE2
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Completed
Location
Blood and Marrow Transplant Program at Northside Hospital
Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant
PHASE2
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
NA
This study will test whether half matched donors with favorable KIR genes w...